InvAscent invested INR 1,400 million in SRV Hospitals to expand its multi-specialty tertiary care network in India.

Information on the Target

SRV Hospitals, founded in 2015, has developed into a robust network comprising five multi-specialty hospitals in key cities including Mumbai, Nashik, and Bengaluru. With a total capacity of 500 beds, SRV Hospitals provides comprehensive tertiary care and has established itself as a leader in high-acuity healthcare services. The organization is renowned for its clinician-first approach, prioritizing patient trust and empathy in every aspect of care.

The recent investment of INR 1,400 million from InvAscent, facilitated through the India Life Sciences Fund IV, aims to augment SRV's multi-specialty tertiary care network. This funding will be directed towards enhancing critical care capabilities and acquiring advanced medical technologies, all in line with SRV's mission to make quality healthcare more accessible at the neighborhood level.

Industry Overview in India

The healthcare sector in India is experiencing rapid transformation, driven by increasing demand for quality medical services and technological advancements. India's healthcare system is characterized by a mix of public and private providers, with priv

View Source

Similar Deals

InvAscent Apex Hospitals Private Limited

2025

Growth Equity & Expansion Capital Hospitals, Clinics & Primary Care Services India
InvAscent Geri Care Health Services

2025

Growth Equity & Expansion Capital Residential & Long-Term Care India
Verlinvest The Eye Foundation

2025

Growth Equity & Expansion Capital Hospitals, Clinics & Primary Care Services India
GIC Asia Healthcare Holdings

2024

Growth Equity & Expansion Capital Hospitals, Clinics & Primary Care Services India
InvAscent Maiva Pharma

2024

Growth Equity & Expansion Capital Biopharmaceuticals India
TA Associates Synokem Pharmaceuticals Ltd.

2023

Growth Equity & Expansion Capital Generic Pharmaceuticals India

InvAscent

invested in

SRV Hospitals

in 2025

in a Growth Equity & Expansion Capital deal

Disclosed details

Transaction Size: $17M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert